Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Urology|March 24, 2011
Intermittent hormonal therapy for prostate cancerFernando Calais da Silva
Urologic Oncology|April 17, 2018
Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteriaMário Fontes-Sousa, Helena Magalhães, Fernando Calais da Silva, et al.
BJU International|January 18, 2014
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?Johannes M Wolff, Per-Anders Abrahamsson, Jacques Irani, et al.
Genetic Testing and Molecular Biomarkers|February 1, 2012
Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancerSilvia Fontenete, Augusto Nogueira, Francisco Pina, et al.
World Journal of Urology|September 28, 2014
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?Axel S Merseburger, Peter Hammerer, Francois Rozet, et al.
European Urology|December 16, 2010
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al.
European Urology|May 1, 2013
Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trialsAlessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patientsAna L Teixeira, Ricardo Ribeiro, Diana Cardoso, et al.
International Urology and Nephrology|August 21, 2020
The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospitalMiguel Gil, João Guerra, Vanessa Andrade, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2002
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]Frans Debruyne, Gary Koch, Peter Boyle, et al.
Pageof 2